Lyell Immunopharma SG&A Expense (TTM) Trends

Lyell Immunopharma Inc (LYEL)

1.62 +0.17 (+11.72%) USD | NASDAQ | Jul 08, 16:00

1.62 0.00 (0.00%) After-Hours: 19:02

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	61.20M
December 31, 2023	66.98M
September 30, 2023	80.16M
June 30, 2023	90.74M
March 31, 2023	102.16M
December 31, 2022	117.31M
September 30, 2022	122.83M

Date	Value
June 30, 2022	117.99M
March 31, 2022	106.65M
December 31, 2021	89.06M
September 30, 2021	72.05M
June 30, 2021	64.38M
March 31, 2021	54.83M
December 31, 2020	46.88M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

46.88M

Minimum

Dec 2020

122.83M

Maximum

Sep 2022

85.23M

Average

84.61M

Median

SG&A Expense (TTM) Benchmarks